Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Gold

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Microbiology|June 29, 2002
Prevalence of the fsr locus in Enterococcus faecalis infectionsS K Pillai, G Sakoulas, H S Gold, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococciH S Gold, S Unal, E Cercenado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance"L R Baden, W Thiemke, A Skolnik, et al.
Lancet (London, England)|July 31, 2001
Linezolid resistance in a clinical isolate of Staphylococcus aureusS Tsiodras, H S Gold, G Sakoulas, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transferC Torres Viera, S Tsiodras, H S Gold, et al.
Infection Control and Hospital Epidemiology|April 20, 2001
A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and controlK E Byers, A M Anglim, C J Anneski, et al.
The Journal of Infectious Diseases|September 9, 1999
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiologyB E Ostrowsky, N C Clark, C Thauvin-Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strainsA M Queenan, C Torres-Viera, H S Gold, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristinG M Eliopoulos, C B Wennersten, H S Gold, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Microbiology|June 29, 2002
Prevalence of the fsr locus in Enterococcus faecalis infectionsS K Pillai, G Sakoulas, H S Gold, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococciH S Gold, S Unal, E Cercenado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance"L R Baden, W Thiemke, A Skolnik, et al.
Lancet (London, England)|July 31, 2001
Linezolid resistance in a clinical isolate of Staphylococcus aureusS Tsiodras, H S Gold, G Sakoulas, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transferC Torres Viera, S Tsiodras, H S Gold, et al.
Infection Control and Hospital Epidemiology|April 20, 2001
A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and controlK E Byers, A M Anglim, C J Anneski, et al.
The Journal of Infectious Diseases|September 9, 1999
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiologyB E Ostrowsky, N C Clark, C Thauvin-Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strainsA M Queenan, C Torres-Viera, H S Gold, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristinG M Eliopoulos, C B Wennersten, H S Gold, et al.
Pageof 2